Cite
HARVARD Citation
Wang, H. et al. (2020). Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib. Thoracic cancer. 11 (3), pp. 594-602. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, H. et al. (2020). Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib. Thoracic cancer. 11 (3), pp. 594-602. [Online].